News
Belay Diagnostics Announces the Validation of Vantage™ Assay for Evaluation of MGMT Promoter Methylation in Cerebrospinal Fluid
July 7, 2025
NIH Award: Multi-omic CSF Assay for the Diagnosis of Brain Cancers
May 9, 2025
Belay Diagnostics Announces US Commercial Launch of Summit™: Breakthrough CSF Testing for CNS Cancer Detection and Management
April 25, 2025
Belay Diagnostics Partners with GenomOncology to Support High-Performance Liquid Biopsy Test for Central Nervous System Cancer Detection
March 25, 2025